Agilent Technologies(A) - 2026 Q1 - Quarterly Results
2026-02-25 21:06
Exhibit 99.1 Agilent Reports First-Quarter Fiscal Year 2026 Financial Results Delivers solid Q1 results, raises FY26 reported revenue outlook and increases non-GAAP EPS guidance while confirming core-revenue growth and margin expansion (3) (1) Life Sciences and Diagnostics Markets Group First-quarter fiscal year 2026 Fiscal year 2026 and second-quarter outlook SANTA CLARA, California, Feb. 25, 2026 — Agilent Technologies, Inc. (NYSE: A) today reported revenue of $1.80 billion for the first quarter ended Jan ...
Energy Recovery(ERII) - 2025 Q4 - Annual Results
2026-02-25 21:06
Fourth Quarter Highlights In conjunction with these financial results, management has released a letter to shareholders reviewing business and financial updates from the fourth quarter and discussing our outlook for 2026. This letter is located under "News and Events" in the "Investors" section on the Energy Recovery website (https://ir.energyrecovery.com/news-events/shareholder-letters). Exhibit 99.1 Energy Recovery Reports its Fourth Quarter 2025 Financial Results SAN LEANDRO, Calif. - February 25, 2026 – ...
Celldex Therapeutics(CLDX) - 2025 Q4 - Annual Report
2026-02-25 21:06
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark one) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 000-15006 CELLDEX THERAPEUTICS, INC. Perryville III Building, 53 Frontage Road, Suite 220, Hampton, New Jersey 08827 (Address of principal executive offi ...
Sterling Infrastructure(STRL) - 2025 Q4 - Annual Results
2026-02-25 21:06
Exhibit 99.1 NEWS RELEASE For Immediate Release: February 25, 2026 Sterling Reports Strong Fourth Quarter and Full Year 2025 Results and Issues Full Year 2026 Guidance THE WOODLANDS, TX – February 25, 2026 – Sterling Infrastructure, Inc. (NasdaqGS: STRL) ("Sterling" or the "Company") today announced strong financial results for the fourth quarter of 2025. The financial comparisons herein are to the prior year quarter, unless otherwise noted. Fourth Quarter 2025 Results: Please note that in the fourth quarte ...
Climb Solutions(CLMB) - 2025 Q4 - Annual Results
2026-02-25 21:06
Exhibit 99.1 "As announced earlier this week, we strengthened our European operations through the acquisition of Interworks, enhancing our Microsoft relationship and expanding our presence to Greece, Albania, Italy, Bulgaria and Romania. This transaction reflects our targeted and accretive M&A strategy, which focuses on expanding our geographic footprint, strengthening our line card and adding complementary capabilities to our platform. Interworks not only broadens our reach in high-growth European markets, ...
The Honest pany(HNST) - 2025 Q4 - Annual Results
2026-02-25 21:06
Exhibit 99.1 The Honest Company Reports Fourth Quarter and Full Year 2025 Financial Results Achieves 2025 Full Year Financial Outlook In Line with Updated Guidance Announces $25 Million Inaugural Share Repurchase Authorization Provides Full Year 2026 Financial Outlook In Line with Long-Term Algorithm LOS ANGELES, Calif. – February 25, 2026 – The Honest Company (Nasdaq: HNST), a personal care company dedicated to creating cleanly-formulated and sustainably-designed products for everyone from babies to adults ...
Catalyst Pharmaceuticals(CPRX) - 2025 Q4 - Annual Report
2026-02-25 21:06
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [Mark One] ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 001-33057 CATALYST PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) Delaware 76-0837053 (State of jurisdiction of incorporation ...
BJ’s(BJRI) - 2026 Q4 - Annual Results
2026-02-25 21:05
EXHIBIT 99.1 BJ's Restaurants, Inc. Reports Fiscal Fourth Quarter and Fiscal Year 2025 Results Issues 2026 Financial Outlook HUNTINGTON BEACH, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- BJ's Restaurants, Inc. (NASDAQ: BJRI) today reported financial results for its fiscal 2025 fourth quarter and year ended December 30, 2025. Fiscal Fourth Quarter 2025 Compared to Fourth Quarter 2024 Total revenues increased 3.2% to $355.4 million Comparable restaurant sales increased 2.6% Restaurant level operating profit was ...
AMERISAFE(AMSF) - 2025 Q4 - Annual Results
2026-02-25 21:05
Exhibit 99.1 G. Janelle Frost President & CEO AMERISAFE 337.463.9052 AMERISAFE ANNOUNCES 2025 FOURTH QUARTER AND YEAR-END RESULTS Reports 10.2% Growth in Voluntary Premiums on Policies Written and Return on Equity of 18.5% in 2025 DeRidder, LA – February 25, 2026 – AMERISAFE, Inc. (Nasdaq: AMSF), a specialty provider of workers' compensation insurance focused on high-hazard industries, today announced results for the fourth quarter and year ended December 31, 2025. | | Three Months Ended | | | | Twelve Mont ...
PROCEPT BioRobotics (PRCT) - 2025 Q4 - Annual Results
2026-02-25 21:05
"In the fourth quarter, we delivered our highest procedure volume to date—approximately 12,200—and sold 65 new systems, marking our strongest capital quarter," said Larry Wood, Chief Executive Officer. "At the same time, we took meaningful steps to position the Company for its next phase of growth. To sharpen our focus on delivering durable procedure growth, we realigned our commercial organization, established a dedicated launch team to reduce activation variability, and implemented a more disciplined hand ...